MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression <i>in vivo</i>
Xin Zhang(Southern Medical University), Zhili Rong(Southern Medical University), Jianqi Feng(Southern Medical University), Zhenhuan Luo(Jinan University), Hongxin Huang(Southern Medical University), Zhen‐Ning Zhang(Shanghai East Hospital), Qinghua Zhou(Jinan University), Sihan Lv(Lanzhou University), Guanjie Huang(Southern Medical University), Bing Luan(Tongji University), Qin-Li Wan(Jinan University), Jun Liu(Jinan University), Dong Wang(Tianjin University of Traditional Chinese Medicine), Xiaoyang Zhao(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Shanshan Zhao(Southern Medical University), Xin Peng(Southern Medical University), Ying Lin(Fujian Medical University), Yongfei Hu(Southern Medical University), Jie Lv(Xuzhou Medical College)
Cited by 54
Related Papers
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
|Cancer Research|2021|280
Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer
|Molecular Cancer|2015|199
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis
|JAMA Network Open|2023|116